---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-109522"
form_type: "8-K"
ticker: "IBIO"
cik: "0001420720"
company_name: "iBio, Inc."
filed_at: "2021-08-26T23:59:59+00:00"
generated_at: "2026-06-29T07:31:30.859716+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# iBio appoints William D. Clark to board of directors

## Summary
- William D. Clark elected as Class III Director, effective August 23, 2021.
- Clark has 30+ years biotech/pharma experience, currently CEO of Genocea Biosciences.
- He receives $40k annual cash retainer, additional fees for Audit and Nominating committees, and a 100k-share stock option.
- Clark will serve on Audit Committee and Nominating and Corporate Governance Committee.

## SEC filing metadata
- accession: 0001104659-21-109522
- form_type: 8-K
- ticker: IBIO
- cik: 0001420720
- company_name: iBio, Inc.
- filed_at: 2021-08-26T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1420720/000110465921109522/0001104659-21-109522-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1420720/000110465921109522/tm2125952d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-109522
- JSON: https://secwatch.observer/filing/0001104659-21-109522.json
- Plain text: https://secwatch.observer/filing/0001104659-21-109522.txt

## Key facts
- Executive change
  William D. Clark was elected as Class III Director at iBio, Inc..
  - Action: elected
  - Role: Class III Director
  source text: On August 23, 2021, the Board of Directors (the “Board”) of iBio, Inc. (the “Company”) elected William D. (Chip) Clark as a Class III Director of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1420720/000110465921109522/0001104659-21-109522-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.